<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Alpha-dystroglycan is a cell surface peripheral membrane protein which binds to the extracellular matrix (ECM), while beta-dystroglycan is a type I integral membrane protein which anchors alpha-dystroglycan to the cell membrane via the N-terminal extracellular domain </plain></SENT>
<SENT sid="1" pm="."><plain>The complex composed of alpha-and beta-dystroglycan is called the dystroglycan complex </plain></SENT>
<SENT sid="2" pm="."><plain>We reported previously a matrix metalloproteinase (MMP) activity that disrupts the dystroglycan complex by cleaving the extracellular domain of beta-dystroglycan </plain></SENT>
<SENT sid="3" pm="."><plain>This MMP creates a characteristic 30 kDa fragment of beta-dystroglycan that is detected by the monoclonal antibody 43DAG/8D5 directed against the C-terminus of beta-dystroglycan </plain></SENT>
<SENT sid="4" pm="."><plain>We also reported that the 30 kDa fragment of beta-dystroglycan was increased in the skeletal and cardiac muscles of cardiomyopathic hamsters, the model animals of sarcoglycanopathy, and that this resulted in the disruption of the link between the ECM and cell membrane via the dystroglycan complex </plain></SENT>
<SENT sid="5" pm="."><plain>In this study, we investigated the proteolysis of beta-dystroglycan in the biopsied skeletal muscles of various human <z:e sem="disease" ids="C0026848" disease_type="Disease or Syndrome" abbrv="">muscular diseases</z:e>, including sarcoglycanopathy, Duchenne <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> (DMD), Becker <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo>, Fukuyama <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo>, Miyoshi <z:hpo ids='HP_0003198'>myopathy</z:hpo>, LGMD2A, facioscapulohumeral <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo>, myotonic <z:mpath ids='MPATH_554'>dystrophy</z:mpath> and <z:e sem="disease" ids="C0011633" disease_type="Disease or Syndrome" abbrv="">dermatomyositis</z:e>/<z:e sem="disease" ids="C0085655" disease_type="Disease or Syndrome" abbrv="">polymyositis</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>We show that the 30 kDa fragment of beta-dystroglycan is increased significantly in sarcoglycanopathy and DMD, but not in the other diseases </plain></SENT>
<SENT sid="7" pm="."><plain>We propose that the proteolysis of beta-dystroglycan may contribute to <z:mp ids='MP_0009415'>skeletal muscle degeneration</z:mp> by disrupting the link between the ECM and cell membrane in sarcoglycanopathy and DMD </plain></SENT>
</text></document>